Our study did not demonstrate statistically significant differences between serum 25(OH)-vitamin D levels in patients with psoriasis and skin cancers compared with psoriatic patients alone, nor a correlation with NGAL levels. This evidence concerns the gene LCN2 and skin neoplasm.